I’m Head of Investor Relations at Ultimovacs, a public listed biotech company developing a therapeutic cancer vaccine (five clinical trials phase II @ 100+ hospitals in 15 countries, FDA Fast Track) and a novel tech platform for cancer treatment. Angel investing in impact, sustainability and tech startups as Managing Partner Farmhouse Capital 🌱 and Venture Partner at a global VC, Antler 🌍 Previously SF, currently Oslo/Nordics 🇳🇴🇪🇺🇺🇸 📚: «The Breakthrough - Immunotherapy and the race to cure cancer» by Charles Graeber